Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-24

FDA Approved: NEFFY — Supplemental Application (ARS Pharmaceuticals Operations, Inc.)

View source ↗

Summary

FDA approves a supplemental application for NEFFY (epinephrine) by ARS Pharmaceuticals Operations, Inc., authorizing changes to the product's labeling and/or ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEFFY (epinephrine)

Snippet

SUPPL AP for NEFFY (EPINEPHRINE)